Skip to Content


In the US, Silodosin (silodosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of symptoms of benign prostatic hyperplasia

α₁a-adrenoceptor antagonist (α₁a-blocker)

Chemical Names

(-)-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroetoxy)phenoxy]etyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide (WHO)

1-(3-Hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoretoxy)phenoxy]etylamino]propyl]-2,3-dihydro-1H-indol-7-carbamid (IUPAC)


Foreign Names

  • Silodosinum (Latin)
  • Silodosin (German)
  • Silodosine (French)
  • Silodosina (Spanish)

Generic Names

  • Silodosin (OS: JAN, BAN)
  • KAD-3213 (IS: Kissei)
  • KMD-3213 (IS: Kissei)

Brand Names

  • Rapaflo
    Actavis, United States; Actavis Specialty Pharmaceuticals, Canada
  • Silodyx
    Almirall, Spain; Recordati, Czech Republic; Recordati, Greece; Recordati, Poland; Takeda, Italy; Zambon, Belgium; Zambon, France; Zambon, Netherlands; Recordati, Lithuania; Recordati, Portugal
  • Silodyx BCNFarma
    Bcnfarma, Spain
  • Silodyx Euromedicines
    Euromedicines, Spain
  • Silodyx Mediwin limited
    Difarmed, Spain
  • Silosin
    Algorithm, Lebanon
  • Urief
    Daiichi Sankyo, China; Eisai, Thailand; Kissei Pharmaceutical, Japan
  • Urorec
    BB Farma, France; Bouchara-Recordati, France; Herbacos - Bofarma, s.r.o., Czech Republic; Mediwin, France; PharmaSwiss, Croatia (Hrvatska); Recordati, Germany; Recordati, Spain; Recordati, Georgia; Recordati, Greece; Recordati, Ireland; Recordati, Israel; Recordati, Italy; Recordati, Lithuania; Recordati, Netherlands; Recordati, Poland; Recordati, Portugal; Recordati, Romania; Recordati, Slovenia; Recordati, Slovakia; Recordati, Turkey; Recordati Ireland, Bosnia & Herzegowina
  • Urorec Euromedicines
    Euromedicines, Spain
  • Urorec Mediwin Limited
    Difarmed, Spain


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.